Have a personal or library account? Click to login
The Intersection between Voluntary Assisted Dying, Suicide and Advance Care Planning in Huntington’s Disease Cover

The Intersection between Voluntary Assisted Dying, Suicide and Advance Care Planning in Huntington’s Disease

By: Ruth C Hosken  
Open Access
|Jun 2024

References

  1. Alothman, D., Marshall, C. R., Tyrrell, E., Lewis, S., Card, T., & Fogarty, A. (2022). Risk of mortality from suicide in patients with Huntington’s disease is increased compared to the general population in England. Journal of neurology, 1–4.
  2. Baliko, L., Csala, B., & Czopf, J. (2004). Suicide in Hungarian Huntington’s disease patients. Neuroepidemiology, 23(5), 258–260.
  3. Bernard, C., Tan, A., Slaven, M., Elston, D., Heyland, D. K., & Howard, M. (2020). Exploring patient-reported barriers to advance care planning in family practice. BMC Family Practice, 21(1), 1–9.
  4. Booij, S. J., Engberts, D. P., Tibben, A., & Roos, R. A. (2013). Euthanasia and physician-assisted suicide in Huntington’s disease in The Netherlands. International psychogeriatrics, 25(2), 339–340.
  5. Booij, S. J., Rödig, V., Engberts, D. P., Tibben, A., & Roos, R. A. (2013). Euthanasia and advance directives in Huntington’s disease: qualitative analysis of interviews with patients. Journal of Huntington’s disease, 2(3), 323–330.
  6. Booij, S. J., Tibben, A., Engberts, D. P., Marinus, J., & Roos, R. A. (2014). Thinking about the end of life: a common issue for patients with Huntington’s disease. Journal of neurology, 261(11), 2184–2191.
  7. Boersma, I., Miyasaki, J., Kutner, J., & Kluger, B. (2014). Palliative care and neurology; time for a paradigm shift. Neurology, 83(6), 561-567.
  8. Cooper, C. S., & Hall, D. A. (2022). Advance Directive Documentation in a Huntington’s Disease Clinic: A Retrospective Chart Review. Tremor and Other Hyperkinetic Movements, 12.
  9. Cutcliffe, J. R., & Links, P. S. (2008). Whose life is it anyway? An exploration of five contemporary ethical issues that pertain to the psychiatric nursing care of the person who is suicidal: Part one. International journal of mental health nursing, 17(4), 236–245.
  10. Dellefield, M. E., & Ferrini, R. (2011). Promoting excellence in end-of-life care: lessons learned from a cohort of nursing home residents with advanced Huntington disease. Journal of Neuroscience Nursing, 43(4), 186–192.
  11. Di Maio, L., Squitieri, F., Napolitano, G., Campanella, G., Trofatter, J. A., & Conneally, P. M. (1993). Suicide risk in Huntington’s disease. Journal of medical genetics, 30(4), 293–295.
  12. Ekkel, M. R., Depla, M. F., Verschuur, E. M., Veenhuizen, R. B., Hertogh, C. M., & Onwuteaka-Philipsen, B. D. (2021). Gaining insight into the views of outpatients with Huntington’s disease regarding their future and the way they deal with their poor prognosis: a qualitative study. BMC palliative care, 20(1), 1–8.
  13. El-Sourady, M., Martin, S., Wong, H. N., & Carroll, T. (2022). A Scoping Review of Palliative Care for Adults with Huntington’s Disease: Current Practice and Future Directions. Journal of Palliative Medicine, 25(3), 488–505.
  14. Epping, E. A., & Paulsen, J. S. (2011). Depression in the early stages of Huntington disease. Neurodegenerative disease management, 1(5), 407–414.
  15. Farrer, L. A., Opitz, J. M., & Reynolds, J. F. (1986). Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. American journal of medical genetics, 24(2), 305–311.
  16. Furfari, K., Zehnder, N., & Abbott, J. (2016). A Case of Attempted Suicide in Huntington’s Disease: Ethical and Moral Considerations. The Journal of clinical ethics, 27(1), 39–42.
  17. Halpin, M. (2012). Accounts of suicidality in the Huntington disease community. OMEGA-Journal of death and dying, 65(4), 317–334.
  18. Ho, A. O. (2014). Suicide: rationality and responsibility for life. The Canadian Journal of Psychiatry, 59(3), 141–147.
  19. Honrath, P., Dogan, I., Wudarczyk, O., Görlich, K. S., Votinov, M., Werner, C. J., … & Reetz, K. (2018). Risk factors of suicidal ideation in Huntington’s disease: literature review and data from Enroll-HD. Journal of neurology, 265(11), 2548–2561.
  20. Hosken, R. (2019). Barriers and facilitators to end of life care in Huntington’s disease-a review of the literature. Australasian Journal of Neuroscience, 29(2), 33–42.
  21. Hubers, A. A. M., Reedeker, N., Giltay, E. J., Roos, R. A., Van Duijn, E., & Van der Mast, R. C. (2012). Suicidality in Huntington’s disease. Journal of affective disorders, 136(3), 550–557.
  22. Hubers, A. A., Van Duijn, E., Roos, R. A., Craufurd, D., Rickards, H., Landwehrmeyer, G. B., … & REGISTRY Investigators of the European Huntington’s Disease Network. (2013). Suicidal ideation in a European Huntington’s disease population. Journal of affective disorders, 151(1), 248–258.
  23. Huntington G. Medical and Surgical Reporter. On Chorea 1872:320-1.
  24. Kachian, Z. R., Cohen-Zimerman, S., Bega, D., Gordon, B., & Grafman, J. (2019). Suicidal ideation and behavior in Huntington’s disease: Systematic review and recommendations. Journal of affective disorders, 250, 319–329.
  25. Keijzer-van Laarhoven, A. J., Touwen, D. P., Tilburgs, B., van Tilborg-den Boeft, M., Pees, C., Achterberg, W. P., & van der Steen, J. T. (2020). Which moral barriers and facilitators do physicians encounter in advance care planning conversations about the end of life of persons with dementia? A meta-review of systematic reviews and primary studies. BMJ open, 10(11), e038528.
  26. Kingma, E. M., van Duijn, E., Timman, R., van der Mast, R. C., & Roos, R. A. (2008). Behavioural problems in Huntington’s disease using the Problem Behaviours Assessment. General hospital psychiatry, 30(2), 155–161. https://doi.org/10.1016/j.genhosppsych.2007.11.005
  27. Kresin, T., Hawgood, J., De Leo, D., & Varghese, F. (2021). Attitudes and arguments in the voluntary assisted dying debate in Australia: what are they and how have they Evolved over time?. International Journal of Environmental Research and Public Health, 18(23), 12327.
  28. Langbehn, D. R. (2022). Longer CAG repeat length is associated with shorter survival after disease onset in Huntington disease. The American Journal of Human Genetics, 109(1), 172–179.
  29. Lennard, C. (2018). Best interest versus advance decisions to refuse treatment in advance care planning for neurodegenerative illness. British Journal of Nursing, 27(21), 1261–1267.
  30. Macleod, A. D., Jury, M. A., & Anderson, T. (2017). The (Palliative) care of Huntington’s disease. Progress in Palliative Care, 25(4), 165–170.
  31. Nance, M. A., Paulsen, J. S. Rosenblatt, A. Wheelock, V., (2011). A Physician’s Guide to the Management of Huntington’s Disease. Huntington’s Disease Society of America, New York.
  32. Paulsen, J. S., Hoth, K. F., Nehl, C., Stierman, L., & Huntington Study Group. (2005). Critical periods of suicide risk in Huntington’s disease. American Journal of Psychiatry, 162(4), 725–731.
  33. Paulsen, J. S., Nehl, C., Hoth, K. F., Kanz, J. E., Benjamin, M., Conybeare, R., … & Turner, B. (2005). Depression and stages of Huntington’s disease. The Journal of neuropsychiatry and clinical neurosciences, 17(4), 496–502.
  34. Pilpel, A., & Amsel, L. (2011). What is wrong with rational suicide. Philosophia, 39(1), 111–123.
  35. Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012). The incidence and prevalence of Huntington’s disease: a systematic review and meta-analysis. Movement Disorders, 27(9), 1083–1091.
  36. Regan, L., Preston, N. J., Eccles, F. J., & Simpson, J. (2018). The views of adults with Huntington’s disease on assisted dying: a qualitative exploration. Palliative Medicine, 32 (4), 708–715.
  37. Rich, K. L., & Butts, J. B. (2004). Rational suicide: uncertain moral ground. Journal of Advanced Nursing, 46(3), 270–278.
  38. Seeber, A. A., Pols, A. J., Hijdra, A., Grupstra, H. F., Willems, D. L., & de Visser, M. (2019). Advance care planning in progressive neurological diseases: lessons from ALS. BMC palliative care, 18(1), 1–10.
  39. Snir, J. T., Ko, D. N., Pratt, B., & McDougall, R. (2022). Anticipated impacts of voluntary assisted dying legislation on nursing practice. Nursing Ethics, 09697330211022409.
  40. van Duijn, E., Fernandes, A. R., Abreu, D., Ware, J. J., Neacy, E., & Sampaio, C. (2021). Incidence of completed suicide and suicide attempts in a global prospective study of Huntington’s disease. BJPsych open, 7(5).
  41. Vaughan, C. L., & Kluger, B. M. (2018). Palliative care for movement disorders. Current treatment options in neurology, 20(1), 1–15.
  42. Werth Jr, J. L., & Holdwick Jr, D. J. (2000). A primer on rational suicide and other forms of hastened death. The Counseling Psychologist, 28(4), 511–539.
  43. Wetzel, H. H., Gehl, C. R., Dellefave–Castillo, L., Schiffman, J. F., Shannon, K. M., Paulsen, J. S., & Huntington Study Group. (2011). Suicidal ideation in Huntington disease: the role of comorbidity. Psychiatry research, 188(3), 372–376.
  44. White, B. P., Willmott, L., Del Villar, K., Hewitt, J., Close, E., Greaves, L. L., … & Downie, J. (2022). Who is eligible for voluntary assisted dying?: Nine medical conditions assessed against five legal frameworks. TheUniversity of New South Wales Law Journal, 45(1), 401–444.
DOI: https://doi.org/10.21307/ajon-2024-002 | Journal eISSN: 2208-6781 | Journal ISSN: 1032-335X
Language: English
Page range: 8 - 28
Published on: Jun 1, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2024 Ruth C Hosken, published by Australasian Neuroscience Nurses Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.